The October survey of 21 telehealth programs found compounded semaglutide at a $175 median, with prices counting memberships and flagging dose increases.
Recap by typeshit. Full story at www.pmg-ky3.com.
Hanmi set Eppe's first four weeks at 129,800 won ahead of a late-month launch, while Novo seeks Korean insurance coverage for Wegovy in high-risk patients.
About half of Australia's roughly 500,000 GLP-1 users pay privately, A$200 to $700 a month, and the authors argue cost hits those with the most obesity hardest.
Ireland's drug pricing body recommended semaglutide over tirzepatide for cost reasons, and Higgins says it's the right call, with a pun he didn't get to use.
The Turkish professor claims income from weight loss shots now far exceeds total AI revenue, a comparison he makes without sourcing in the snippet.
Researchers behind a new Australian study are asking whether GLP-1 drugs could play a role in cystic fibrosis. Tap through for what they're looking at.
Timed to World Arthritis Day, HCPLive looks at whether adding tirzepatide to ixekizumab could help calm psoriatic arthritis.
Loading…